LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

High Capacity Centrifuge to Be Introduced at AACC Annual Meeting

By LabMedica International staff writers
Posted on 01 Aug 2016
Print article
Image: The Centrifuge 5920 R, designed for high-throughput applications (Photo courtesy of Eppendorf).
Image: The Centrifuge 5920 R, designed for high-throughput applications (Photo courtesy of Eppendorf).
A new refrigerated centrifuge that combines extraordinary high capacity with enhanced temperature management in a very compact and ergonomic product design is to be unveiled at the 2016 AACC Annual Meeting & Clinical Lab Expo (Philadelphia, PA, USA).

The Eppendorf (Hamburg, Germany) 5920 R centrifuge, which will be on display in Booth 3636 of the expo, features extraordinary high capacity and performance. Its capacity of up to four x 1,000 milliliter bottles or 52 x 50 milliliter conical tubes makes it the ideal instrument for high-throughput applications.

Centrifuge 5920 R accommodates standard one-liter Nalgene bottles setting a new standard in the tabletop centrifuge segment. Compared to other custom-made one liter bottles the Nalgene bottle is narrow and allows for a better pellet compared to wider bottles. The higher capacity enables the user to process a higher volume in fewer runs. Furthermore, the high-capacity buckets were designed to allow both tubes and plates to be used in the same rotor bucket.

The centrifuge offers a powerful state-of-the-art refrigeration system with advanced temperature management. Dynamic compressor control technology and a FastTemp pro function allows precise and automated pre-cooling based on a pre-programmable time and date.

Centrifuge 5920 R boasts an advanced operating system with outstanding functionality that includes a menu-driven, multi-lingual operation menu with large backlit display, which has the capacity to save up to 99 user-defined programs and has five program keys for easy access to routine programs.

“With laboratories under increasing pressure to increase efficiencies and throughput we understand the challenges that researchers face in their work,” said Peter Schreiner, global product manager centrifugation at Eppendorf. “The very large capacity and precise temperature management offered by the Centrifuge 5920 R means researchers can be assured that not only are their samples safe, but that they are saving time, money, and energy with this system.”

Related Links:
AACC Annual Meeting & Clinical Lab Expo
Eppendorf
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Blood Gas and Chemistry Analysis System
Edan i500
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.